|
![]() |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name LMA International N.V. Headquarters 7-A Abraham de Veerstraat, Willemstad, Curacao; Singapore; Singapore |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : ANN2879J1070 Financial Auditors: PricewaterhouseCoopers (2005) Incorporation Date: July 28, 1998 Tel: (5999) 4613709 |
|
Company Description |
| The Company is engaged in develop, market and distribute medical equipment, principally the laryngeal mask airway line of products. LMA designs, develops, markets and distributes medical equipment, principally the LMATM laryngeal mask airway range of supraglottic airway management devices. These devices are used by physicians to allow respiration, provide ventilation to, and support the airway of patients undergoing surgical procedures and life-saving interventions. LMA has an office in Jersey, | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first quarter of 2011, total net operating revenues increased with 10.69%, from USD 26,716 thousands to USD 29,573 thousands. Operating result increased from USD 3,376 thousands to USD 4,165 thousands which means 23.37% change. The results of the period increased 22.69% reaching USD 3,563 thousands at the end of the period against USD 2,904 thousands last year. Return on equity (Net income/Total equity) went from 3.06% to 4.15%, the Return On Asset (Net income / Total Asset) went from 2.60% to 3.16% and the Net Profit Margin (Net Income/Net Sales) went from 10.87% to 12.05% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 31.30% compared to 19.78% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.29 to 2.65 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |

|
| SELECT CURRENCY |
| Figures in: USD | EUR |
|
2011 Q1 (cons) |
2010 Y (cons) |
|
![]() | ||
| Non-Audited | Audited | |
![]() | ||
| CEIC Company Financials (New) | CEIC Company Financials (New) | |
![]() | ||
| Unit | Thousands | Thousands |
![]() | ||
![]() | ||
Total Assets |
112,719 |
126,705 |
![]() | ||
Current Assets |
57,882 |
71,570 |
![]() | ||
Total Liabilities |
26,869 |
46,208 |
![]() | ||
Shareholders Equity |
85,850 |
80,497 |
![]() | ||
Current Liabilities |
21,864 |
41,186 |
![]() | ||
| * All the accounts are in USD. | ||
![]() | ||
Total Operating Revenue |
29,573 |
108,139 |
![]() | ||
Operational Profit (Loss) |
4,165 |
8,350 |
![]() | ||
Net Profit (Loss) |
3,230 |
8,243 |
![]() | ||
| * All the accounts are in USD. | ||
| Profitability Ratios | ||
![]() | ||
Return on Assets (ROA) |
3.16% |
6.4% |
![]() | ||
Annualised Return on Assets (ROA) |
12.64% |
6.4% |
![]() | ||
Return on Equity (ROE) |
4.15% |
10.07% |
![]() | ||
Annualised Return on Equity (ROE) |
16.6% |
10.07% |
![]() | ||
Return on Sales (ROS) |
14.27% |
7.71% |
![]() | ||
Return on Capital |
3.92% |
9.64% |
![]() | ||
Gross Profit Margin |
60.48% |
58.92% |
![]() | ||
Operating Profit Margin |
10.92% |
7.62% |
| Efficiency Ratios | ||
![]() | ||
Inventory Turnover |
0.01x |
0.03x |
![]() | ||
Current asset turnover |
0.01x |
0.02x |
![]() | ||
Fixed-asset turnover |
0.02x |
0.07x |
![]() | ||
Asset Turnover |
0.00x |
0.01x |
| Valuation figures and ratios | ||
![]() | ||
Earning Before Interests and Taxes (EBIT) |
4,220 |
8,342 |
![]() | ||
EBITDA |
4,696 |
9,217 |
![]() | ||
Enterprise value |
159,712 |
137,141 |
![]() | ||
Enterprise Value / EBITDA |
34.01 |
14.88 |
![]() | ||
Bookvalue (BV) |
85,850 |
80,497 |
![]() | ||
Net Cash |
15,095 |
31,929 |
| Liquidity Ratios | ||
![]() | ||
Current Ratio |
2.65% |
1.74% |
![]() | ||
Quick ratio |
1.57% |
1.23% |
![]() | ||
Doom's day ratio |
0.69% |
0.78% |
| Leverage Ratios | ||
![]() | ||
Leverage ratio |
1.31% |
1.57% |
![]() | ||
Interest Coverage Ratio |
2,110% |
80.21% |
![]() | ||
Debt to equity |
31.3% |
57.4% |
| Market ratios | ||
![]() | ||
Market Capitalization/EBITDA |
28.21 |
16.11 |
![]() | ||
Price/Book Ratio |
1.47 |
1.7 |
![]() | ||
Market Cap / Net cash |
8.78 |
4.65 |
![]() | ||
Market cap/Shareholder equity |
1.54 |
1.84 |
| Trend Ratios | ||
![]() | ||
Revenue Trend |
0% |
1% |
![]() | ||
Net Income Trend |
1.17% |
-3.22% |
![]() | ||
Operating Income Trend |
1.23% |
-2.61% |
![]() | ||